| Literature DB >> 31905888 |
Yair Olovaldo Santiago-Saenz1, Rebeca Monroy-Torres2, Diana Olivia Rocha-Amador3, Alma Delia Hernández-Fuentes1.
Abstract
Quelites are Mexican wild plants, reportedEntities:
Keywords: arsenic; quelites; supplementation
Mesh:
Substances:
Year: 2019 PMID: 31905888 PMCID: PMC7019896 DOI: 10.3390/nu12010098
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flow diagram of patient progress through the phases of the randomized trial.
General characteristics of participants of the supplemented and control group.
| Baseline Variables | Supplemented | Control | |
|---|---|---|---|
| Age (years) | 11.80 ± 0.41 | 12 ± 0.36 | 3 NS |
| Weight (kg) | 47.31 ± 10.54 | 48.95 ± 11.33 | NS |
| Height (cm) | 150.31 ± 6.74 | 153.30 ± 7.21 | NS |
| 1 H/A interpretation (Z-Score) | NS | ||
| Normal height | 15 ± 82.19 | 12 ± 91.42 | |
| 2 BMI interpretation (Z-Score) | NS | ||
| Obesity | 2 ± 10.14 | 2 ± 16.05 | |
| Overweight | 5 ± 33.67 | 3 ± 19.36 | |
| Normal weight | 8 ± 31.94 | 7 ± 35.02 | |
| Fat mass (%) | 21.92 ± 14.71 | 23.02 ± 14.07 | NS |
| Muscular mass (%) | 33.46 | 32.12 ± 8.95 | NS |
| Waist circumference (cm) | 71.19 ± 12.05 | 71.48 ± 9.44 | NS |
| Abdominal circumference (cm) | 76.28 ± 11.58 | 79.33 ± 10.27 | NS |
The table shows the mean ± standard deviation (SD) for each baseline variable and the p-value according to the independent samples t-Test (p < 0.05). 1 H/A: height-for-age [ages 5–19 years (Z-Score)]; 2 BMI: body mass index for age [ages 5–19 years (Z-Score)]; 3 NS: not significant.
General characteristics for men, women, and total participants included in the supplementation study.
| Baseline Variables | Total Population | Men | Women | |
|---|---|---|---|---|
| Age (years) | 11.88 ± 0.32 | 11.84 ± 0.37 | 11.92 ± 0.26 | 3 NS |
| Weight (kg) | 48.13 ± 10.72 | 48.07 ± 10.89 | 48.19 ± 10.98 | NS |
| Height (cm) | 151.78 ± 7.01 | 152.56 ± 7.28 | 151.00 ± 6.64 | NS |
| 1 H/A interpretation (Z-Score) | NS | |||
| Normal height | 27 ± 98.42 | 13 ± 86.24 | 14 ± 93.37 | |
| 2 BMI interpretation (Z-Score) | NS | |||
| Obesity | 4 ± 31.26 | 1 ± 9.32 | 3 ± 17.21 | |
| Overweight | 8 ± 35.74 | 5 ± 35.11 | 3 ± 21.17 | |
| Normal weight | 15 ± 42.31 | 8 ± 32.29 | 7 ± 35.18 | |
| Fat mass (%) | 22.46 ± 14.16 | 13.98 ± 12.64 | 30.32 ± 10.74 | <0.001 |
| Muscular mass (%) | 32.80 ± 10.03 | 40.47 | 25.67 ± 2.93 | <0.001 |
| Waist circumference (cm) | 71.34 ± 10.77 | 71.20 ± 11.77 | 71.47 ± 10.20 | NS |
| Abdominal circumference (cm) | 77.81 ± 10.96 | 75.62 ± 10.90 | 79.84 ± 11.01 | NS |
The table shows the mean ± standard deviation (SD) for each baseline variable and the p-value according to the independent samples t-Test (p < 0.05). 1 H/A: height-for-age in men and women ages 5–19 years (Z-Score); 2 BMI: body mass index for age in men and women ages 5–19 years (Z-Score); 3 NS: not significant.
Daily intake of energy and nutrients in supplemented and control group.
| Nutrients | Supplemented | Control | |
|---|---|---|---|
| Energy (kcal) | 2006.04 ± 5.07 | 2000.12 ± 3.49 | <0.002 |
| Protein (g) | 70.05 ± 27.52 | 69.96 ± 27.96 | 1 NS |
| Fat (g) | 70.02 ± 33.71 | 66.15 ± 29.66 | NS |
| Cholesterol (mg) | 284.21 ± 169.46 | 282.59 ± 180.64 | NS |
| Carbohydrates (g) | 290.38 ± 96.12 | 273.41 ± 51.34 | NS |
| Sugar (g) | 32.36 ± 31.67 | 30.02 ± 36.32 | NS |
| Fiber (g) | 21.09 ± 12.20 | 20.17 ± 8.91 | NS |
| Vitamin A-Retinol (µg) | 767.04 ± 182.09 | 753.62 ± 173.48 | NS |
| Vitamin B1(mg) | 1.15 ± 0.50 | 1.09 ± 0.38 | NS |
| Vitamin B2 (mg) | 1.23 ± 0.57 | 1.21 ± 0.45 | NS |
| Vitamin B6 (mg) | 0.94 ± 0.55 | 0.81 ± 0.46 | NS |
| Vitamin B12 (µg) | 1.93 ± 1.12 | 1.91 ± 1.27 | NS |
| Vitamin C (mg) | 52.47 ± 45.74 | 34.03 ± 29.79 | NS |
| Folic acid (µg) | 186.39 ± 174.18 | 136.25 ± 88.08 | NS |
| Niacin (mg) | 12.28 ± 6.60 | 9.08 ± 5.67 | NS |
| Vitamin E (mg) | 2.67 ± 2.01 | 1.97 ± 3.73 | NS |
| Ca (mg) | 947.59 ± 361.72 | 937.66 ± 363.81 | NS |
| Fe (mg) | 14.82 ± 7.30 | 13.29 ± 4.43 | NS |
| K (mg) | 1605.14 ± 654.99 | 1094.35 ± 566.09 | <0.05 |
| Mg (mg) | 303.39 ± 220.35 | 240.26 ± 184.69 | NS |
| Na (mg) | 2501.90 ± 811.04 | 1949.78 ± 721.42 | NS |
| P (mg) | 631.40 ± 304.63 | 595.08 ± 264.43 | NS |
| Se (µg) | 51.95 ± 30.00 | 50.06 ± 23.06 | NS |
| Zn (mg) | 4.68 ± 2.60 | 4.26 ± 2.00 | NS |
The values show the mean ± SD for each nutrient and the p-value according to the independent samples t-Test (p < 0.05). 1 NS: not significant.
Daily intake of energy and nutrients of all adolescents and by group (men and women) included in the supplementation study.
| Nutrients | Total Population | Men | Women | |
|---|---|---|---|---|
| Energy (kcal) | 2003.07 ± 1.24 | 2345.11 ± 1.35 | 1490 ± 1.11 | <0.001 |
| Protein (g) | 70.24 ± 32.01 | 87.84 ± 27.96 | 43.85 ± 19.88 | <0.001 |
| Fat (g) | 68.19 ± 29.36 | 81.03 ± 26.83 | 48.93 ± 8.62 | <0.001 |
| Cholesterol (mg) | 283.63 ± 127.38 | 398.28 ± 142.17 | 111.67 ± 101.48 | <0.001 |
| Carbohydrates (g) | 281.85 ± 82.19 | 321.01 ± 72.98 | 223.13 ± 27.13 | <0.001 |
| Sugar (g) | 31.07 ± 29.70 | 38.01 ± 36.21 | 20.65 ± 14.98 | 1 NS |
| Fiber (g) | 20.64 ± 8.56 | 22.81 ± 10.68 | 17.39 ± 3.81 | NS |
| Vitamin A-Retinol (µg) | 759.60 ± 128.11 | 877.67 ± 143.62 | 582.50 ± 105.69 | <0.001 |
| Vitamin B1(mg) | 1.13 ± 0.54 | 1.41 ± 0.52 | 0.69 ± 0.11 | <0.001 |
| Vitamin B2 (mg) | 1.22 ± 0.65 | 1.60 ± 0.55 | 0.64 ± 0.30 | <0.001 |
| Vitamin B6 (mg) | 0.87 ± 0.56 | 1.11 ± 0.50 | 0.50 ± 0.34 | <0.001 |
| Vitamin B12 (µg) | 1.92 ± 1.10 | 2.46 ± 1.01 | 1.11 ± 0.88 | <0.001 |
| Vitamin C (mg) | 43.30 ± 44.13 | 52.41 ± 50.86 | 29.65 ± 11.81 | NS |
| Folic acid (µg) | 161.33 ± 198.05 | 235.89 ± 219.80 | 49.49 ± 21.16 | <0.002 |
| Niacin (mg) | 10.69 ± 6.75 | 13.97 ± 6.61 | 5.76 ± 1.50 | <0.001 |
| Vitamin E (mg) | 2.33 ± 1.80 | 2.67 ± 1.80 | 1.82 ± 1.87 | NS |
| Ca (mg) | 942.63 ± 270.27 | 1133.50 ± 332.51 | 656.33 ± 255.79 | <0.001 |
| Fe (mg) | 14.10 ± 9.59 | 18.31 ± 9.57 | 7.79 ± 2.49 | <0.001 |
| K (mg) | 1349.47 ± 436.12 | 1597.94 ± 445.58 | 976.75 ± 407.24 | <0.001 |
| Mg (mg) | 271.83 ± 222.07 | 328.83 ± 238.09 | 186.33 ± 164.75 | NS |
| Na (mg) | 2226.77 ± 658.33 | 2993.61 ± 776.12 | 1076.50 ± 501.16 | <0.001 |
| P (mg) | 613.67 ± 307.02 | 754 ± 220.09 | 403.17 ± 225.73 | <0.001 |
| Se (µg) | 51.33 ± 29.33 | 67.56 ± 19.44 | 27 ± 14.33 | <0.001 |
| Zn (mg) | 4.46 ± 2.94 | 5.99 ± 2.49 | 2.15 ± 1.37 | <0.001 |
The values show the mean ± SD for each nutrient and the p-value according to the independent samples t-Test (p < 0.05). 1 NS: not significant.
Figure 2Concentrations of (a) Hb (Hemoglobin) (mean ± SD) and (b) UMDA (Urinary malondialdehyde) (mean ± SD) before, during, and after 4 weeks of supplementation in the supplemented and control group (W0: baseline; W1: week 1; W2: week 2; W3: week 3; W4: week 4). * Statistically significant difference between groups according to the independent samples t-Test (p < 0.001).
Urinary MDA concentrations in men, women, and total participants before, during, and after 4 weeks of supplementation.
| Supplement | Men | Women | Control | Men | Women | |||
|---|---|---|---|---|---|---|---|---|
| Weeks | Urinary MDA concentrations (µM/g creatinine) | |||||||
| Baseline | 3.01 ± 0.85 | 3.26 ± 0.97 | 2.63 ± 0.48 | NS | 2.88 ± 0.61 | 3.44 ± 0.35 | 2.59 ± 0.51 | <0.014 |
| 2 | 1.59 ± 0.89 | 1.84 ± 1.06 | 1.21 ± 0.36 | NS | 2.90 ± 0.56 | 3.47 ± 0.39 | 2.61 ± 0.38 | <0.004 |
| 4 | 0.98 ± 0.80 | 1.13 ± 1.01 | 0.75 ± 0.28 | NS | 2.94 ± 0.57 | 3.51 ± 0.26 | 2.66 ± 0.44 | <0.006 |
The values show the mean ± SD of UMDA (Urinary malondialdehyde) concentrations (µM/g creatinine) in supplemented and the control group before, during and after 4 weeks of supplementation. The week zero represents baseline. NS: no statistically significant difference between men and women of the same group per week according to the independent samples t-Test.
Urinary MDA concentrations in men of the supplemented and control group and women of the supplemented and control group, before, during, and after 4 weeks of supplementation.
| Men | Control | Women | Control | |||
|---|---|---|---|---|---|---|
| Weeks | Urinary MDA concentrations (µM/g creatinine) | |||||
| Baseline | 3.26 ± 0.97 | 3.44 ± 0.35 | NS | 2.63 ± 0.48 | 2.59 ± 0.51 | NS |
| 2 | 1.84 ± 1.06 | 3.47 ± 0.39 | <0.014 | 1.21 ± 0.36 | 2.61 ± 0.38 | <0.001 |
| 4 | 1.13 ± 1.01 | 3.51 ± 0.26 | <0.001 | 0.75 ± 0.28 | 2.66 ± 0.44 | <0.001 |
The values show the mean ± SD of UMDA (Urinary malondialdehyde) concentrations (µM/g creatinine) in men of supplemented and control group and women of supplemented and control group, before, during and after 4 weeks of supplementation. The week zero represents baseline. NS: no statistically significant difference between men of supplemented and control group and women of supplemented and control group per week according to the independent samples t-Test.
Urinary As concentrations in the supplemented and control group during 4 weeks of supplementation.
| Supplemented | Men | Women | Control | Men | Women | |||
|---|---|---|---|---|---|---|---|---|
| Weeks | Urinary As concentrations (µg/g creatinine) | |||||||
| 0 | 56.85 | 57.42 | 52.09 | NS | 51.34 | 53.98 | 50.81 | NS |
| 1 | 53.60 | 53.90 | 53.48 | NS | 52.57 | 53.13 | 52.19 | NS |
| 2 | 2.02 | 3.95 | 0.45 | NS | 56.49 | 58.62 | 54.02 | NS |
| 3 | 0.29 | 0.27 | 0.30 | NS | 50.97 | 54.53 | 49.76 | <0.05 |
| 4 | 0.29 | 0.27 | 0.30 | NS | 54.60 | 54.78 | 54.45 | NS |
The values show the median of UAs (Urinary arsenic) concentrations (µg/g creatinine) in the supplemented and control group. The week zero represents baseline. NS: no statistically significant difference between men and women of the same group per week according to the Mann–Whitney U test.
Figure 3UAs (Urinary arsenic) (median) concentration by sex in the supplemented group (a) and control group (b) (W0: baseline; W1: week 1; W2: week 2; W3: week 3; W4: week 4). * Statistically significant difference by sex according to the Mann–Whitney U test (p < 0.05).
Figure 4(a) Comparison of UAs (Urinary arsenic) concentrations (median) in the supplemented group and control group (W0: baseline; W1: week 1; W2: week 2; W3: week 3; W4: week 4). ** Statistically significant difference between groups according to the Mann–Whitney U test (p < 0.001); (b) Comparison of UAs concentration (median) between supplemented and control group per week of treatment. The Friedman and Wilcoxon tests were carried out to determine differences between weeks of supplementation.